載入...

NI-22 NON-ENHANCING TUMOR RESPONSE USING QUANTITATIVE T2 MAPS PREDICTS SURVIVAL IN GLIOBLASTOMA TREATED WITH BEVACIZUMAB

BACKGROUND: Malignant gliomas are known to contain proportions of both neovascularized and infiltrative, non-enhancing tumor (NET). Additionally, a substantial proportion of treated tumors can have NET progression prior to contrast enhancement. There remains significant need for objective evaluation...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Ellingson, Benjamin, Pope, Whitney, Nghiemphu, Phioanh, Lai, Albert, Cloughesy, Timothy
格式: Artigo
語言:Inglês
出版: Oxford University Press 2014
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218347/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou264.21
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!